Angiography-Based Blood Flow Quantification After Revascularization in Acute Coronary Syndromes

Area of Science:

• Cardiology
• Interventional Cardiology
• Medical Imaging

Background:

• Impaired coronary blood flow (CBF) post-percutaneous coronary intervention (PCI) is a significant predictor of mortality in acute coronary syndromes (ACS).
• A novel angiography-based method using automatic contrast bolus tracking was developed for CBF quantification.
• This study investigated the clinical impact of this angiography-derived CBF measurement on major adverse cardiovascular events (MACE) in ACS patients post-PCI.

Purpose of the Study:

• To assess the association between post-PCI CBF, quantified via angiography, and the occurrence of MACE in patients with ACS.
• To determine if angiography-based CBF measurement can serve as a prognostic tool for risk stratification in ACS patients undergoing PCI.

Main Methods:

• A prospective, multicenter, nested case-control study was conducted.
• Patients presenting with ACS were included, and propensity scores were used to match cases with and without MACE at 1-year follow-up.
• Coronary blood flow (CBF) was automatically measured from angiograms acquired after PCI.

Main Results:

• The study included 162 patients (mean age 68.3 years, 83% male, 33% diabetes).
• Lower post-PCI CBF was observed in ST-segment-elevation myocardial infarction (STEMI) patients compared to other ACS presentations (74.1 mL/min vs. 89.1-95.7 mL/min, P=0.046).
• Patients with low post-PCI CBF (<54.3 mL/min) exhibited a significantly increased risk of MACE (HR 2.11, P=0.001).

Conclusions:

• Automatic quantification of CBF using angiography after PCI is significantly associated with MACE in ACS patients.
• Post-PCI CBF measurement derived from angiography holds potential for risk stratification.
• This approach may facilitate personalized management strategies for ACS patients.